ロード中...
Efficacy and safety of tofacitinib for the treatment of chronic plaque psoriasis: a systematic review and meta-analysis
BACKGROUND: Tofacitinib is an oral Janus kinase (JAK) inhibitor that targets JAK1 and JAK3, and thus regulates immune response. Therefore, tofacitinib is used to treat immune-mediated inflammatory diseases such as chronic plaque psoriasis. The objective of this study was to systematically assess the...
保存先:
| 出版年: | J Int Med Res |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6567701/ https://ncbi.nlm.nih.gov/pubmed/31096817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519847414 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|